Finally there is hope for a long COVID treatment. This is what it is
Ensitrelvir, a new antiviral drug, has been shown to shorten the symptoms of mild to moderate COVID-19 and, in addition, has the potential to prevent long-term COVID-19, research has shown. Here’s everything you need to know about the drug, can it really prevent long-term COVID, and why the experts are still skeptical about it.
Joanna Swanson is Europe correspondent at the Thomson Reuters Foundation based in Brussels covering politics, culture, business, climate change, society, economies and inclusive tech. With specific focus in breaking news, she has covered some of the world's most significant stories.